Device Trial Radar · NCT05511181
BioWave High-frequency Neurostimulation Versus TENS for the Treatment of Chronic Low Back Pain
Last checked: Nov 20, 2026Latest source record: Jul 3, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
120
Actual
Start
Aug 15, 2022
Primary completion
Apr 12, 2023
Study completion Jun 30, 2023
Sponsor
- Lead sponsor
- BioWave CorporationNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Center For Interventional Pain and Spine; Yale University; University of Wisconsin, Madison
- First posted
- Aug 22, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This will be a multicenter randomized crossover clinical trial comparing the therapeutic efficacy of BioWave therapy versus TENS for the management of chronic low back pain. This study also aims to evaluate the impact of these therapies on physical activity, patient perception of therapeutic efficacy, and activities of daily living.
Conditions
- Chronic Pain
- Lumbar Pain Syndrome
- Low Back Pain
Interventions
BioWaveDevice
The BioWave device is called BioWaveGO. It is a FDA 510(k) cleared high frequency sinusoidal neurostimulator
TENSDevice
The TENS device is called Intensity 5000. It is a FDA 510(k) cleared TENS device
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Brief Pain Inventory relative to baselineTime frame: completed pre-treatment at the initiation of the study (1st in-clinic treatment), at the 2 week follow up, at week 4, prior to the 2nd in-clinic treatment, and at the 6 week follow up
- Change in Visual Analogue Scale relative to baselineTime frame: completed pre-treatment and post treatment for the in-clinic visit at week 1 and week 4, as well as at the 2 week and 6 week follow up visits
- Change in Patient Global Impression of Change relative to baselineTime frame: completed pre-treatment and post treatment for the in-clinic visit at week 1 and week 4, as well as at the 2 week and 6 week follow up visits
1 more outcomes with a free account
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Yale
New Haven, Connecticut
Carolinas Pain Center
Huntersville, North Carolina
Center for Interventional Pain and Spine
Lancaster, Pennsylvania
1 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.